---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000068"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-10-21T10:01:36+00:00"
generated_at: "2026-10-21T10:05:23.906368+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Elevance Q3 revenue $50.4B, adjusted EPS $6.99; raises FY26 adjusted EPS guidance to at least $29.00

## Summary
- Q3 operating revenue $50.4B, up 0.7% YoY; diluted EPS $6.27 and adjusted EPS $6.99, including a net non-operating benefit of $1.85 per share.
- FY2026 guidance raised to at least $22.00 diluted EPS and at least $29.00 adjusted EPS, cash flow at least $6.5B; 2027 adjusted EPS growth seen at least 12% off $26.75 baseline.
- Health Benefits revenue $43.4B (+3%) but operating gain fell to $0.4B from $0.6B on targeted investments; margin 1.0% vs 1.4%; membership 44.9M, down 487k YoY.
- Carelon revenue $19.3B (+5%), operating gain $0.9B (+17%) on risk-based solutions and specialty pharmacy; benefit expense ratio improved 70 bps to 90.6%.
- Q4 dividend $1.72/share payable Dec 18, 2026 to holders of record Dec 4; Q3 buybacks 0.8M shares for $330M at $398.75 average; $5.0B authorization remains.

## SEC filing metadata
- accession: 0001156039-26-000068
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-10-21T10:01:36+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/0001156039-26-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/elv-20261021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000068
- JSON: https://secwatch.observer/filing/0001156039-26-000068.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.